Tech Company Financing Transactions
Arbovax Funding Round
Piedmont Angel Network and private investors participated in a $1.4 million Series A venture round for Arbovax. The round was announced on 6/16/2008.
Transaction Overview
Company Name
Announced On
6/16/2008
Transaction Type
Venture Equity
Amount
$1,430,000
Round
Series A
Investors
Piedmont Angel Network (Charlton Owensby)
Proceeds Purpose
The investment will allow Arbovax to move forward with its Dengue Fever Virus program which will include early-stage testing of the technology in a mouse model, said Malcolm Thomas, CEO of Arbovax.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
617 Hutton St. 101
Raleigh, NC 27606
USA
Raleigh, NC 27606
USA
Phone
Website
Email Address
Overview
Biotechnology company working on vaccines against insect-borne viral diseases like Dengue fever.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Chris English
Chief Executive Officer
Malcolm Thomas
Browse more venture capital transactions:
Prev: 6/16/2008: i2we venture capital transaction
Next: 6/16/2008: PlantSense venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs